• menu

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
    Eculizumab
    |
    Weekly News Recap #Phispers Eculizumab
    Genmab buys ProfoundBio for US$ 1.8 bn; FDA okays Vanda’s Fanapt to treat bipolar disorder

    Genmab buys ProfoundBio for US$ 1.8 bn; FDA okays Vanda’s Fanapt to treat bipolar disorder

    April kicked off with Danish drugmaker Genmab buying ProfoundBio for US$ 1.8 billion in cash. ProfoundBio is a clinical stage b...

    Impressions : 1139

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.